The US market for IVDs will exhibit moderate growth through 2027, driven by the aging US population and the shift toward value-based health care, which will fuel uptake of newer tests with improved diagnostic accuracy and reduced turnaround time.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IVDs in the US across a 10-year period.


The use of MDx tests will expand rapidly over the forecast period.

Which MDx tests will experience the highest growth throughout the forecast period?

How will adoption of MDx tests affect the other test segments in the IVD market?

The PAMA reimbursement revision will promote widespread pricing pressures and increasing laboratory consolidation in the US.

How must vendors adjust their strategies to adapt to this trend?

How will the growth prospects of the market be affected?

How will test volumes between the different facility types be affected?

The IVD competitive landscape consists of large MNCs as well as smaller niche competitors specializing in specific segments and diseases. 

Which companies were leading the IVD market in 2018?

How do strategies differ between MNCs and smaller companies in this space?

What are the key purchasing criteria laboratories consider when selecting an IVD manufacturer?

Table of contents

  • United States
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Key Report Updates
      • Procedures Covered
      • Products Covered
    • Version History
    • In Vitro Diagnostics Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Product Improvements and Innovations
        • Mergers, Acquisitions, and Partnerships
        • Product Portfolio Management
      • Market Developments
    • Clinical Chemistry Test Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • General Chemistry Tests
        • Diabetes Tests
        • Therapeutic Drug Monitoring Tests
        • Drug of Abuse Testing
        • Specific Protein Tests
        • Cardiac Marker
        • Blood Gas
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Immunoassay Test Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Allergy Tests
        • Anemia Tests
        • Bone Metabolism Tests
        • Cardiac Marker Tests
        • Fertility/Hormone Tests
        • Infectious Disease Tests
        • Specific Protein
        • Thyroid Tests
        • Tumor Marker Tests
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Microbiology Test Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Pathological Culture Tests
        • Blood Culture Tests
        • Identification/Antibiotic Susceptibility Testing
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Hematology and Coagulation Test Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • General Screening and Anticoagulation Monitoring Tests
        • Prothrombin Time Tests
        • D-Dimer Tests
        • Fibrin Formation and Degradation Tests
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Molecular Diagnostic Test Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Infectious Disease Tests
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Benjamin Li, BBA

Benjamin Li is a senior analyst within the Hardware Medtech Insights team at Decision Resources Group, with extensive knowledge in healthcare IT, women's health imaging, urology, large-joint reconstruction, spinal implants, and dental implants. Benjamin holds a Bachelor's degree in Business Administration from the Schulich School of Business, with a certificate in Managing International Trade and Investment.


Related Reports

Diagnostic Imaging Equipment Servicing | Medtech 360 | Market Insights | United States

The US diagnostic imaging equipment servicing market will be negatively impacted by the ongoing shift toward value-based care in the US, which is resulting in budget constraints and hospital con...

View Details

Liquid Biopsy | Medtech 360 | Market Insights | United States

The US market for liquid biopsy tests will exhibit rapid growth through 2028, driven by the aging US population, the shift toward value-based health care, the noninvasive nature of liquid b...

View Details

Biopsy Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European biopsy device market will continue to grow modestly through 2028, driven largely by growth in the percutaneous soft tissue biopsy...

View Details

Diagnostic Imaging Systems | Medtech 360 | Market Insights | China

The Chinese diagnostic imaging system market will experience moderate growth over the forecast period as health care reform efforts bolster hospital spending in all tiers of the hea...

View Details